Laboratory Analytical Instruments - Insider Trading Data

Insiders are officers, directors, or significant investors. This page shows insider sentiment and transactions for the Laboratory industry. Research shows that insider trades are predictive of future stock returns. By examining insider trades for an industry, we can understand what well-informed people think of the overall future industry prospects.

Laboratory Analytical Instruments - Insider Buy/Sell Ratio

Insider selling and buying is a useful indicator for analyzing the market because it serves as a proxy for their optimism or pessimism in their own companies. By looking at ratio of total selling and buying across the entire market, we might be able to draw some conclusions about the future market.

We offer two charts here. The first one shows the total dollar volume of buying and selling by insiders. The second chart shows the ratio of the number of insiders selling, vs. the number of insiders buying. In both charts, we filter out trades made by indirect holders (such as trusts), and 10% owners (who, although considered an 'insider' by the SEC, do not actually manage the companies in which they are considered insiders).

Corporate Insider Buy Sell Ratio (Dollar Volume) - Laboratory Analytical Instruments
Corporate Insider Buy Sell Ratio (Insider Count) - Laboratory Analytical Instruments
Laboratory Analytical Instruments - Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

Tran
Date
Security Form Insider Code 10b5-1 Direct Share
Price
Shares
Changed
2025-03-28 ILMN / Illumina, Inc. 4 Meister Keith A. A - Award D 625
2025-03-21 RVTY / Revvity, Inc. 4 Gonzales Anita A - Award D 732
2025-03-20 NAUT / Nautilus Biotechnology, Inc. 4 Patel Sujal M P - Purchase D 0.9982 23,933
2025-03-19 NAUT / Nautilus Biotechnology, Inc. 4 Patel Sujal M P - Purchase D 0.9949 53,300
2025-03-19 EYPT / EyePoint Pharmaceuticals, Inc. 4 Duker Jay S. J - Other D 6.155 -20,000
2025-03-19 HBIO / Harvard Bioscience, Inc. 4 Cote Jennifer F - Taxes D 0.6886 -5,687
2025-03-19 HBIO / Harvard Bioscience, Inc. 4 Green James W F - Taxes D 0.6886 -38,413
2025-03-19 PACB / Pacific Biosciences of California, Inc. 4 Van Oene Mark A - Award D 449,176
2025-03-19 PACB / Pacific Biosciences of California, Inc. 4 Farmer Michele A - Award D 89,835
2025-03-19 PACB / Pacific Biosciences of California, Inc. 4 HENRY CHRISTIAN O A - Award D 920,810
2025-03-17 A / Agilent Technologies, Inc. 4 Gonsalves Rodney S - Sale D 121.981 -1,908
2025-03-17 TXG / 10x Genomics, Inc. 4 Hindson Benjamin J. A - Award D 120,535
2025-03-17 TXG / 10x Genomics, Inc. 4 Saxonov Serge A - Award D 171,428
2025-03-17 TXG / 10x Genomics, Inc. 4 Taich Adam A - Award D 133,928
2025-03-15 QTRX / Quanterix Corporation 4 Sriram Vandana F - Taxes D 7.06 -229
2025-03-15 QTRX / Quanterix Corporation 4 Toloue Masoud F - Taxes D 7.06 -1,242
2025-03-14 BIO / Bio-Rad Laboratories, Inc. 4 Crowley Michael S - Sale D 247.0614 -3,000
2025-03-14 BIO / Bio-Rad Laboratories, Inc. 4 Crowley Michael M - Exercise D 159.32 3,000
2025-03-14 BNGO / Bionano Genomics, Inc. 4 Holmlin R. Erik F - Taxes D 3.47 -198
2025-03-14 A / Agilent Technologies, Inc. 4 KOH BOON HWEE F - Taxes D 121.18 -546
2025-03-14 A / Agilent Technologies, Inc. 4 SCANGOS GEORGE A A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 Rataj Sue H. A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 KOH BOON HWEE A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 Anand Mala A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 FIELDS HEIDI Heidi K. Fields Living Trust A - Award I 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 Podolsky Daniel K A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 BRAWLEY OTIS W A - Award D 121.18 812
2025-03-14 A / Agilent Technologies, Inc. 4 Dolsten Mikael A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 BRAWLEY OTIS W A - Award D 121.18 1,819
2025-03-14 A / Agilent Technologies, Inc. 4 WILSON DOW R A - Award D 121.18 1,819
2025-03-10 BRKR / Bruker Corporation 4 Bures Thomas P - Purchase D 47.395 500
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 2,049
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe M - Exercise D 2,946
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 9,817
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Yan Ming M - Exercise D 7,366
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 4,908
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Holder Michael M - Exercise D 2,908
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie M - Exercise D 10,313
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 29,467
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin M - Exercise D 15,708
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.36 -7,998
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Jiang Wenbin F - Taxes D 4.36 -4,658
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 4.36 -799
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Busque Philippe F - Taxes D 4.36 -1,148
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.36 -2,911
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Yan Ming F - Taxes D 4.36 -2,185
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.36 -4,017
2025-03-10 CTKB / Cytek Biosciences, Inc. 4 Barnett Valerie F - Taxes D 4.36 -1,912
2025-03-09 RPID / Rapid Micro Biosystems, Inc. 4 Wilson John J. Addington F - Taxes D 2.39 -9,872
2025-03-09 RPID / Rapid Micro Biosystems, Inc. 4 Spignesi Robert G. Jr. F - Taxes D 2.39 -10,650
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)